Satintape well a good review as that is what I read. I am surprised by a lot off comments that don't seem to have actually read the announcement.
Operating costs of 32 is as far as I know one of the lowest in the industry. That is AuD so at $52 USD which is the current thermal contract price MrV has about $40 head room to export. Keeping in mind the 32 is delivered to local generation so a bit cheaper now on Opex but have to rail to port at what cost???? My guess is lower than 40 bucks
Then there is ash% that some one stated must be 20 to be able to export and hence why MRV focused on stanwell as it can't be sold???? Read the Resource reserve and we are at 22% ash with mid 70's recoveries.
Add to that it seem only 33% has been considered so the company seems to indicate up side
Another comment was others have tried like rio, yes but they did not fail they sold coal for 20 years to tarong so in fact proves the point.
Anyway some of the lowest costs in the country, massive deposit and it seems 15-20 a tonne cheaper than Stanwell. Yeah that will never get funded!!!!!! Well informed comment
Capital cost of only 250 million for an 11 billion project etc etc ........
On reflection they have stated they will fix kingaroy, demobilise, rehab, fix environment, fix community, all the things that last clown of a CEO could not do. They brought 7 million in without dilution and have advanced three assets and we still have cash......
Other than deliver well ahead of what they promise they would. I am with you guys this company sucks who would want a board and team that just continue to deliver above expectation. I have a good idea sell and sell quickly...... Clowns
- Forums
- ASX - By Stock
- MRV
- Ann: South Burnett Project Pre-Feasibility Exceeds Expectations
Ann: South Burnett Project Pre-Feasibility Exceeds Expectations, page-19
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MRV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online